Coherus Oncology annual net debt
2013
2018
2019
2020
2021
2022
2023
2024
2025
Coherus Oncology Net Debt Growth & History (CHRS)
Coherus Oncology's net debt was −$85.6M for fiscal 2025.
View full Coherus Oncology company overviewCoherus Oncology annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$85.6M | $35.4M | — |
| 2024 | 2024-12-31 | −$121.0M | −$25.6M | — |
| 2023 | 2023-12-31 | −$95.4M | −$41.2M | — |
| 2022 | 2022-12-31 | −$54.2M | $352.3M | — |
| 2021 | 2021-12-31 | −$406.5M | $121.6M | — |
| 2020 | 2020-12-31 | −$528.1M | −$436.5M | — |
| 2019 | 2019-12-31 | −$91.6M | −$19.2M | — |
| 2018 | 2018-12-31 | −$72.4M | — | — |
| 2013 | 2013-12-31 | −$38.4M | — | — |
Coherus Oncology quarterly net debt
Q4.13
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q4.22
Q4.23
Q4.24
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$80.5M | $95.3M | — |
| Q1 2026 | 2026-03-31 | −$75.2M | — | — |
| Q4 2025 | 2025-12-31 | −$85.6M | $35.4M | — |
| Q3 2025 | 2025-09-30 | −$62.7M | — | — |
| Q2 2025 | 2025-06-30 | −$175.9M | — | — |
| Q4 2024 | 2024-12-31 | −$121.0M | −$25.6M | — |
| Q4 2023 | 2023-12-31 | −$95.4M | −$41.2M | — |
| Q4 2022 | 2022-12-31 | −$54.2M | $352.3M | — |
| Q4 2021 | 2021-12-31 | −$406.5M | $121.6M | — |
| Q3 2021 | 2021-09-30 | −$279.6M | −$877,000 | — |
| Q2 2021 | 2021-06-30 | −$249.1M | −$38.7M | — |
| Q1 2021 | 2021-03-31 | −$166.7M | $12.9M | — |
| Q4 2020 | 2020-12-31 | −$528.1M | −$436.5M | — |
| Q3 2020 | 2020-09-30 | −$278.7M | −$126.4M | — |
| Q2 2020 | 2020-06-30 | −$210.4M | −$185.9M | — |
| Q1 2020 | 2020-03-31 | −$179.7M | −$180.0M | — |
| Q4 2019 | 2019-12-31 | −$91.6M | −$19.2M | — |
| Q3 2019 | 2019-09-30 | −$152.2M | — | — |
| Q2 2019 | 2019-06-30 | −$24.5M | — | — |
| Q1 2019 | 2019-03-31 | $298,000 | — | — |
| Q4 2018 | 2018-12-31 | −$72.4M | — | — |
| Q4 2013 | 2013-12-31 | −$38.4M | — | — |
Coherus Oncology net debt trends
Over the last five fiscal years, Coherus Oncology's net debt increased from −$528.1M to −$85.6M, a change of $442.5M. The latest reported quarter, Q2 2026, shows −$80.5M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Coherus Oncology source filings ↗